Genprex Rg

Genprex, Inc. is a clinical‑stage gene‑therapy biotech focused on oncology and diabetes. It develops its non‑viral OncoPReX delivery platform and lead candidates REQORSA (GPX‑001) for NSCLC/SCLC and GPX‑002 for diabetes, targeting unmet needs.

Headquarters: United States (USA)

Genprex Rg Logo
Company Profile
  • Employees: 13
  • HQ: Austin
Traded Instruments
+ Add Instrument 1
Symbol Name Type Exchange Currency ISIN Status Actions
GNPX Genprex Rg
Cap: 0.0B
EQUITY NMS USD US3724461047 Active
📈
Home Login